EAACI Congress 2023 Back

09 - 11 June 2023 Hamburg, Germany

Martin Chapman

United States of America

Martin Chapman

Dr. Chapman’s pioneering research for over 40 years has focused on the molecular properties of allergens and their role in causing allergic diseases, such as asthma and food allergy. Dr. Chapman’s team have determined the structures of important allergens from dust mites, cockroaches, mold and peanut, as well as developing state-of-the-art tests for measuring these allergens in homes, schools and workplaces. Dr. Chapman’s latest research involves gene editing of cat allergen using CRISPR. He has published over 250 peer-reviewed articles, reviews, and book chapters. Dr. Chapman has received numerous NIH grants and served on the editorial boards of allergy and immunology journals. Dr. Chapman is a Fellow of the American Academy of Allergy, Asthma and Immunology (AAAAI) and has served as a reviewer for the National Institute of Allergy and Infectious Disease, the National Heart Lung and Blood Institute and Food Allergy Research and Education (FARE).